250% Production Volume Growth: The Digest’s 2020 Multi-Slide Guide to Amyris’s Business Model and 148% Revenue Growth

A stock worth watching is Amyris on heels of their Q4 2019 earnings call. The financial highlights, the latest numbers on their Biossance soon to be billion dollar brand, recent production results like the 10 Q4 products that totaled a product volume of 1,578 tons which is a new quarterly record and a total 2019 product volume of 3,700 tons which is up 90% over 2018 product volume, and let’s not forget their 2020 expectations of commercializing 2-3 new molecules.